BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 21502316)

  • 1. Fetal cardiac troponin isoforms rescue the increased Ca2+ sensitivity produced by a novel double deletion in cardiac troponin T linked to restrictive cardiomyopathy: a clinical, genetic, and functional approach.
    Pinto JR; Yang SW; Hitz MP; Parvatiyar MS; Jones MA; Liang J; Kokta V; Talajic M; Tremblay N; Jaeggi M; Andelfinger G; Potter JD
    J Biol Chem; 2011 Jun; 286(23):20901-12. PubMed ID: 21502316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenesis associated with a restrictive cardiomyopathy mutant in cardiac troponin T is due to reduced protein stability and greatly increased myofilament Ca2+ sensitivity.
    Parvatiyar MS; Pinto JR
    Biochim Biophys Acta; 2015 Feb; 1850(2):365-72. PubMed ID: 25450489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac troponin T isoforms affect the Ca(2+) sensitivity of force development in the presence of slow skeletal troponin I: insights into the role of troponin T isoforms in the fetal heart.
    Gomes AV; Venkatraman G; Davis JP; Tikunova SB; Engel P; Solaro RJ; Potter JD
    J Biol Chem; 2004 Nov; 279(48):49579-87. PubMed ID: 15358779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A troponin T mutation that causes infantile restrictive cardiomyopathy increases Ca2+ sensitivity of force development and impairs the inhibitory properties of troponin.
    Pinto JR; Parvatiyar MS; Jones MA; Liang J; Potter JD
    J Biol Chem; 2008 Jan; 283(4):2156-66. PubMed ID: 18032382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of cardiac troponin T N-terminal deletion and phosphorylation on myofilament function.
    Sumandea MP; Vahebi S; Sumandea CA; Garcia-Cazarin ML; Staidle J; Homsher E
    Biochemistry; 2009 Aug; 48(32):7722-31. PubMed ID: 19586048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The miscommunicative cardiac cell: when good proteins go bad.
    Gomes AV; Venkatraman G; Potter JD
    Ann N Y Acad Sci; 2005 Jun; 1047():30-7. PubMed ID: 16093482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac troponin T mutations: correlation between the type of mutation and the nature of myofilament dysfunction in transgenic mice.
    Montgomery DE; Tardiff JC; Chandra M
    J Physiol; 2001 Oct; 536(Pt 2):583-92. PubMed ID: 11600691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infantile restrictive cardiomyopathy: cTnI-R170G/W impair the interplay of sarcomeric proteins and the integrity of thin filaments.
    Cimiotti D; Fujita-Becker S; Möhner D; Smolina N; Budde H; Wies A; Morgenstern L; Gudkova A; Sejersen T; Sjöberg G; Mügge A; Nowaczyk MM; Reusch P; Pfitzer G; Stehle R; Schröder RR; Mannherz HG; Kostareva A; Jaquet K
    PLoS One; 2020; 15(3):e0229227. PubMed ID: 32182250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac troponin T mutation R141W found in dilated cardiomyopathy stabilizes the troponin T-tropomyosin interaction and causes a Ca2+ desensitization.
    Lu QW; Morimoto S; Harada K; Du CK; Takahashi-Yanaga F; Miwa Y; Sasaguri T; Ohtsuki I
    J Mol Cell Cardiol; 2003 Dec; 35(12):1421-7. PubMed ID: 14654368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional analysis of a unique troponin c mutation, GLY159ASP, that causes familial dilated cardiomyopathy, studied in explanted heart muscle.
    Dyer EC; Jacques AM; Hoskins AC; Ward DG; Gallon CE; Messer AE; Kaski JP; Burch M; Kentish JC; Marston SB
    Circ Heart Fail; 2009 Sep; 2(5):456-64. PubMed ID: 19808376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of cardiac troponin T with COOH-terminal truncation accelerates cross-bridge interaction kinetics in mouse myocardium.
    Stelzer JE; Patel JR; Olsson MC; Fitzsimons DP; Leinwand LA; Moss RL
    Am J Physiol Heart Circ Physiol; 2004 Oct; 287(4):H1756-61. PubMed ID: 15165990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac troponin mutations and restrictive cardiomyopathy.
    Parvatiyar MS; Pinto JR; Dweck D; Potter JD
    J Biomed Biotechnol; 2010; 2010():350706. PubMed ID: 20617149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations in thin filament regulation induced by a human cardiac troponin T mutant that causes dilated cardiomyopathy are distinct from those induced by troponin T mutants that cause hypertrophic cardiomyopathy.
    Robinson P; Mirza M; Knott A; Abdulrazzak H; Willott R; Marston S; Watkins H; Redwood C
    J Biol Chem; 2002 Oct; 277(43):40710-6. PubMed ID: 12186860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in Troponin that cause HCM, DCM AND RCM: what can we learn about thin filament function?
    Willott RH; Gomes AV; Chang AN; Parvatiyar MS; Pinto JR; Potter JD
    J Mol Cell Cardiol; 2010 May; 48(5):882-92. PubMed ID: 19914256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of two new regions in the N-terminus of cardiac troponin T that have divergent effects on cardiac contractile function.
    Mamidi R; Mallampalli SL; Wieczorek DF; Chandra M
    J Physiol; 2013 Mar; 591(5):1217-34. PubMed ID: 23207592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations in human cardiac troponin I that are associated with restrictive cardiomyopathy affect basal ATPase activity and the calcium sensitivity of force development.
    Gomes AV; Liang J; Potter JD
    J Biol Chem; 2005 Sep; 280(35):30909-15. PubMed ID: 15961398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using baculovirus/insect cell expressed recombinant actin to study the molecular pathogenesis of HCM caused by actin mutation A331P.
    Bai F; Caster HM; Rubenstein PA; Dawson JF; Kawai M
    J Mol Cell Cardiol; 2014 Sep; 74():64-75. PubMed ID: 24793351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variant R94C in
    Ezekian JE; Clippinger SR; Garcia JM; Yang Q; Denfield S; Jeewa A; Dreyer WJ; Zou W; Fan Y; Allen HD; Kim JJ; Greenberg MJ; Landstrom AP
    J Am Heart Assoc; 2020 Mar; 9(5):e015111. PubMed ID: 32098556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypercontractile mutant of ventricular myosin essential light chain leads to disruption of sarcomeric structure and function and results in restrictive cardiomyopathy in mice.
    Yuan CC; Kazmierczak K; Liang J; Kanashiro-Takeuchi R; Irving TC; Gomes AV; Wang Y; Burghardt TP; Szczesna-Cordary D
    Cardiovasc Res; 2017 Aug; 113(10):1124-1136. PubMed ID: 28371863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The C terminus of cardiac troponin I stabilizes the Ca2+-activated state of tropomyosin on actin filaments.
    Galińska A; Hatch V; Craig R; Murphy AM; Van Eyk JE; Wang CL; Lehman W; Foster DB
    Circ Res; 2010 Mar; 106(4):705-11. PubMed ID: 20035081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.